ArticleNeuro-oncology2020

ΔNp73/ETS2 complex drives glioblastoma pathogenesis- targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma.

Maren Cam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.